semaglutide and cirrhosis targets MASH molecular pathways beyond weight loss Semaglutide Shows Promise for Treating

Follow the dosage escalation below to reduce the risk of gastrointestinal adverse reactions [see Warnings and Precautions (5.7), Adverse Reactions (6.1)]

For patients with obstructive sleep apnea and obesity, Zepbound is the first and only medication approved by the FDA specifically to treat OSA

The researchers also couldn't determine if the patients actually took their medication or if they started and then stopped taking semaglutide at some point and how this might have impacted their risk

The medication's Summary of Product Characteristics (SmPC) does not list male infertility or reduced sperm quality as recognised adverse effects